0000899243-22-020998.txt : 20220603 0000899243-22-020998.hdr.sgml : 20220603 20220603164636 ACCESSION NUMBER: 0000899243-22-020998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220601 FILED AS OF DATE: 20220603 DATE AS OF CHANGE: 20220603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Simon Mark CENTRAL INDEX KEY: 0001400717 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39103 FILM NUMBER: 22995313 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cabaletta Bio, Inc. CENTRAL INDEX KEY: 0001759138 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: (267) 759-3100 MAIL ADDRESS: STREET 1: 2929 ARCH STREET STREET 2: SUITE 600 CITY: PHILADELPHIA STATE: PA ZIP: 19104 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-01 0 0001759138 Cabaletta Bio, Inc. CABA 0001400717 Simon Mark C/O CABALETTA BIO, INC. 2929 ARCH STREET, SUITE 600 PHILADELPHIA PA 19104 1 0 0 0 Stock Option (Right to buy) 1.28 2022-06-01 4 A 0 22000 0.00 A 2032-05-31 Common Stock 22000 22000 D This option shall vest in full upon the earlier of (1) June 1, 2023 or (2) the date of the next annual meeting of the Corporation's stockholders. Exhibit 24: Power of Attorney /s/ Michael Gerard, Attorney-in-Fact 2022-06-03 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY
                       For Executing Forms 3, 4 and 5

        Know all by these presents, that the undersigned hereby constitutes and
appoints each of Steven Nichtberger, M.D., Anup Marda and Michael Gerard, each
acting singly, his true and lawful attorney-in-fact from June 1, 2022 to:

    (1) Execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or 10% shareholder of Cabaletta Bio, Inc.
(the "Company"), forms and authentication documents for EDGAR Filing Access;

    (2) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or 10% shareholder of the Company, Forms
3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of
1934 and the rules thereunder;

    (3) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to complete the execution of any such Form
3, 4 or 5, complete and execute any amendment or amendments thereto, and the
timely filing of such form with the United States Securities and Exchange
Commission and any other authority; and

    (4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interests of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
his discretion.

    The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform all and every act and thing whatsoever requisite,
necessary, and proper to be done in the exercise of any of the rights and
powers herein granted, as fully for all intents and purposes as the such
attorney-in-fact might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or his substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming
any of the undersigned's responsibilities to comply with Section 16 of the
Securities Exchange Act of 1934, as amended.

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    By this Power of Attorney, the undersigned further revokes all previous
powers of attorney relating to the undersigned's obligations to file Forms 3, 4
and 5 in respect of the Company's securities under Section 16(a) of the
Securities Exchange Act of 1934 and related matters.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date first set forth above.

                                   /s/ Mark Simon
                                   -------------------------------
                                   Name: Mark Simon, MBA